Literature DB >> 11008000

Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases.

A R Van Rompay1, M Johansson, A Karlsson.   

Abstract

Nucleoside monophosphate kinases catalyze the reversible phosphotransferase reaction between nucleoside triphosphates and monophosphates, i.e., monophosphates are converted to their corresponding diphosphate form. These enzymes play an important role in the synthesis of nucleotides that are required for a variety of cellular metabolic processes, as well as for RNA and DNA synthesis. Human tissues contain a thymidylate kinase, a uridylate-cytidylate kinase, five isozymes of adenylate kinase, and several guanylate kinases. Nucleoside monophosphate kinases are also required for the pharmacological activation of therapeutic nucleoside and nucleotide analogs. This overview is focused on the substrate specificity, tissue distribution, and subcellular location of the mammalian monophosphate kinases and their role in the activation of nucleoside and nucleotide analogs.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11008000     DOI: 10.1016/s0163-7258(00)00048-6

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  60 in total

1.  Phosphorylation of thymidine and AZT in heart mitochondria: elucidation of a novel mechanism of AZT cardiotoxicity.

Authors:  Edward E McKee; Alice T Bentley; Matthew Hatch; Joel Gingerich; Delia Susan-Resiga
Journal:  Cardiovasc Toxicol       Date:  2004       Impact factor: 3.231

2.  Determinants of individual variation in intracellular accumulation of anti-HIV nucleoside analog metabolites.

Authors:  Elijah Paintsil; Ginger E Dutschman; Rong Hu; Susan P Grill; Chuan-Jen Wang; Wing Lam; Fang-Yong Li; Musie Ghebremichael; Veronika Northrup; Yung-Chi Cheng
Journal:  Antimicrob Agents Chemother       Date:  2010-11-15       Impact factor: 5.191

3.  Imexon enhances gemcitabine cytotoxicity by inhibition of ribonucleotide reductase.

Authors:  Nicholas O Roman; Betty K Samulitis; Lee Wisner; Terry H Landowski; Robert T Dorr
Journal:  Cancer Chemother Pharmacol       Date:  2010-03-26       Impact factor: 3.333

4.  Is 3'-deoxy-3'-(18)F-fluorothymidine a better marker for tumour response than (18)F-fluorodeoxyglucose?

Authors:  Sven N Reske; Sandra Deisenhofer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-07       Impact factor: 9.236

5.  Metabolic analysis of senescent human fibroblasts reveals a role for AMP in cellular senescence.

Authors:  Werner Zwerschke; Sybille Mazurek; Petra Stöckl; Eveline Hütter; Erich Eigenbrodt; Pidder Jansen-Dürr
Journal:  Biochem J       Date:  2003-12-01       Impact factor: 3.857

Review 6.  Direct and indirect quantification of phosphate metabolites of nucleoside analogs in biological samples.

Authors:  Nagsen Gautam; Jawaher Abdullah Alamoudi; Sushil Kumar; Yazen Alnouti
Journal:  J Pharm Biomed Anal       Date:  2019-10-03       Impact factor: 3.935

7.  Gemcitabine-based chemogene therapy for pancreatic cancer using Ad-dCK::UMK GDEPT and TS/RR siRNA strategies.

Authors:  Soukaina Réjiba; Christelle Bigand; Céline Parmentier; Amor Hajri
Journal:  Neoplasia       Date:  2009-07       Impact factor: 5.715

8.  Analysis of deoxyribonucleotide pools in human cancer cell lines using a liquid chromatography coupled with tandem mass spectrometry technique.

Authors:  Wei Zhang; Shenglan Tan; Elijah Paintsil; Ginger E Dutschman; Elizabeth A Gullen; Edward Chu; Yung-Chi Cheng
Journal:  Biochem Pharmacol       Date:  2011-05-18       Impact factor: 5.858

9.  Molecular cloning and characterization of a novel adenylate kinase 3 gene from Clonorchis sinensis.

Authors:  Guang Yang; Xinbing Yu; Zhongdao Wu; Jin Xu; Linxia Song; Hongmei Zhang; Xuchu Hu; Nancai Zheng; Lingchen Guo; Jian Xu; Jianfeng Dai; Chaoneng Ji; Shaohua Gu; Kang Ying
Journal:  Parasitol Res       Date:  2005-03-03       Impact factor: 2.289

10.  Identification and biochemical characterization of adenylate kinase 1 from Clonorchis sinensis.

Authors:  Pei Liang; Fan Zhang; Wenjun Chen; Xuchu Hu; Yan Huang; Shan Li; Mengyu Ren; Lei He; Ran Li; Xuerong Li; Jin Xu; Zhongdao Wu; Gang Lu; Xinbing Yu
Journal:  Parasitol Res       Date:  2013-02-28       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.